Australia markets open in 30 minutes

Immunic, Inc. (IMUX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1200+0.0100 (+0.90%)
At close: 04:00PM EDT
1.1000 -0.02 (-1.79%)
After hours: 05:19PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-97,924
-93,612
-120,407
-92,945
-44,017
-
Depreciation & amortisation
105
111
77
85
39
-
Stock-based compensation
7,873
7,102
7,929
5,949
2,747
-
Change in working capital
7,829
15,048
9,530
-9,279
-2,365
-
Accounts payable
1,625
817
799
176
1,000
-
Other working capital
-75,545
-71,162
-65,256
-83,300
-46,270
-
Other non-cash items
1,540
-
-
8,625
-
1,540
Net cash provided by operating activities
-75,284
-70,828
-65,144
-83,233
-46,124
-
Cash flows from investing activities
Investments in property, plant and equipment
-261
-334
-112
-67
-146
-
Purchases of investments
-
-
-9,629
0
-
-
Sales/maturities of investments
4,357
9,796
-
-
-
-
Other investing activities
10,551
-
-
-
-
10,551
Net cash used for investing activities
4,096
9,462
-9,741
-67
-146
-
Cash flows from financing activities
Common stock issued
1,044
853
39,584
42,749
144,431
-
Other financing activities
-270
-
-
-
-
-270
Net cash used provided by (used for) financing activities
75,446
1,033
95,760
42,841
144,431
-
Net change in cash
4,551
-60,071
19,882
-40,589
98,083
-
Cash at beginning of period
92,761
106,745
86,863
127,452
29,369
-
Cash at end of period
97,019
46,674
106,745
86,863
127,452
-
Free cash flow
Operating cash flow
-75,284
-70,828
-65,144
-83,233
-46,124
-
Capital expenditure
-261
-334
-112
-67
-146
-
Free cash flow
-75,545
-71,162
-65,256
-83,300
-46,270
-